Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure

NCT03082508 is registered in ClinicalTrials.gov with LoneStar Heart, Inc. as lead sponsor.

NCT NCT03082508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03082508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Trial to Establish the Efficacy and Safety of Algisyl in Patients With Moderate to Severe Heart Failure
Lead sponsor
LoneStar Heart, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2017
Completion date
January 31, 2024
Enrollment
240 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

dilated cardiomyopathy, heart failure, heart failure with reduced ejection fraction